Regulators need to pay more attention to controlling CRISPR, the revolutionary gene-editing tool, says Jennifer Doudna.
One year on: Doudna, a University of California biochemist who helped invent CRISPR technology in 2012, wrote an editorial in Science yesterday titled “CRISPR’s unwanted anniversary.”
The anniversary is that of the announcement by a Chinese scientist, He Jiankui, that he had created gene-edited twin girls. That was a medical felony as far as Doudna is concerned, an unnecessary experiment that violated the doctor’s rule to avoid causing harm and ignored calls not to proceed.
A moratorium? Forget about it. So how do we stop this from happening again? Since the “CRISPR babies” debacle, scientists have talked about self-regulation. One idea was a moratorium: a self-imposed ban of a few years before anyone tries using the technology on the human germline again. (The germline refers to embryos, sperm, and eggs—anything that, if you edit it, will cause changes that pass down through the generations.) But that's not going to cut it, says Doudna.
“I believe that moratoria are no longer strong enough countermeasures,” she writes, adding that there are “moments in the history of every disruptive technology that can make or break its public perception and acceptance.”
Tinkering and temptation: Gene-editing has uncounted uses—in research, altering plants, and making novel human medicines. The toolbox will only get better, Doudna says, and “will soon make it possible to introduce virtually any change to any genome with precision." This revolutionary step can “improve the well-being of millions of people.”
But the same advances mean that “the temptation to tinker with the human germline” is not going to go away, Doudna says. That language—tinkering and temptation—makes it clear she thinks designer babies are a Pandora’s box we might not want to open.
Doudna specifically calls out Russia, since a scientist there is bidding to use the technology again to make babies.
Rogue concern: In her editorial, Doudna never says why designer babies worry her so much. But at least part of the answer is that the China case showed how CRISPR gives great power to small teams of scientists—and how finger-wagging is not enough to stop them from doing wrong.
In her own laboratory, Doudna has been dedicating time toward developing antidotes and countermeasures to CRISPR, in case it’s used in even more frightening ways—as a weapon, for example.
Time to regulate: The test ahead is how society will use CRISPR. According to Doudna, “stakeholders must engage in thoughtfully crafting regulations of the technology without stifling it.”
That sure doesn’t sound like strong medicine. But don’t underestimate what it means when one of the heroes of the CRISPR story suggests that regulators (that is, governments) “engage, lead, and act.”
Conflict of interest: Doudna helped invent the CRISPR tool, and she’s one of its biggest beneficiaries, too. A disclosure at the end of her item lists five companies she started and another five on whose boards she sits, including drug giant Johnson & Johnson, all of which has made her a gene-editing multi-multimillionaire.
So if she’s telling you she needs help control what she created, believe her.
Biotechnology and health
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Some deaf children in China can hear after gene therapy treatment
After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at night?
Scientists just drafted an incredibly detailed map of the human brain
A massive suite of papers offers a high-res view of the human and non-human primate brain.
Three people were gene-edited in an effort to cure their HIV. The result is unknown.
CRISPR is being used in an experimental effort to eliminate the virus that causes AIDS.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.